Phathom Pharmaceuticals

We’re excited to have received a 3rd #FDAapproval of our first-in-class medicine! This approval is a welcomed development for #GERD patients, bringing a new treatment for heartburn relief in Non-Erosive GERD. Read more about what this means for the millions of people with this disease: https://bit.ly/4cLc2qe

As #WomensHistoryMonth2025 comes to a close, we honor the trailblazing women who have paved the way for progress, and those who continue to break barriers every day. We are especially grateful for the incredible women of our #PhathomPhamily who lead with excellence, inspire future generations, and drive meaningful change. Their impact extends far beyond this month, and we remain committed to fostering empowerment and opportunity for all. Let’s keep the momentum going, because progress happens every day!

In case you missed it, our Chief Financial & Business Officer Molly Henderson recently sat down with other industry leaders for the FT Live panel “Making a Business Case to Fund an Upcoming Launch.” The conversation covered key strategies for securing pre-launch funding, common pitfalls companies face when presenting their business case, and how biotech leaders can make smart investment decisions to maximize launch success. The discussion offered valuable takeaways for organizations preparing for an upcoming launch or refining their funding strategies. Watch the full panel discussion here: https://bit.ly/4l0rHX9

This Women’s History Month (and every day) we celebrate the incredible women in our #PhathomPhamily who are driving innovation, breaking barriers, and shaping the future of healthcare. Their many contributions not only advance science but also foster greater equity, representation, and progress across our industry. At Phathom, we are proud to amplify their voices, recognize their impact, and champion strong female leadership that inspires lasting change. Because honoring and supporting women in STEM isn’t just a moment, it’s a movement! #WomenInSTEM #InspiringChange #WomensHistoryMonth

Today, we reported strong financial results for the fourth quarter and full year of 2024, along with key business updates. As we reflect on our first full year of launch, we are proud of the progress we’ve made in expanding access to our first and only treatment option of its kind for #GERD and look forward to building on this momentum. Read the #news here: https://lnkd.in/ekhsMk4P

Our Chief Financial and Business Officer Molly Henderson will be participating in a panel conversation at the upcoming FT Live event, "Optimizing the Biopharmaceutical Product Launch Process" on March 13 at 10:35am E.T. Molly will be joined by other industry financial leaders to provide insights on building compelling business cases for pre-launch funding, maximizing launch investments, and navigating common challenges to securing investments. Register here at no cost to join the discussion live in New York City or virtually: https://bit.ly/4hH1b2V

At Phathom, our core values – Perseverance, Humble, Accountable, Transparent and Entrepreneurial (PHATE) – define who we are and how we work. As we kicked off the new year, we asked our employees to vote for the Phathom value that resonates most with them. The results are in, and the winning phavorite value is… Perseverance! This choice speaks to the heart of our culture and our Phamily’s commitment to solving challenges and pushing boundaries to make a meaningful impact for the patients we seek to serve. We pride ourselves on fostering an environment where innovation, collaboration, and resilience drive success. Want to work for a company where these values are rooted in what we do every day? Learn more about our culture, benefits, and why people love being part of the #PhathomPhamily: https://lnkd.in/e2gmhDfp #GuidedByPHATE #PhathomValues #Perseverance #LifeAtPhathom

Join us on Thursday, March 6 at 8:30 AM ET for a live conference call with Phathom management to discuss our fourth quarter and full year 2024 financial results, along with updates on the progress of our first-in-class GERD treatment in its first full year on the market. Read more: https://bit.ly/3EQsgCm

Congratulations to our phirst ever pHalcons Club winners! These annual sales awards recognize our #PhathomPhamily members who are top performers and go above and beyond to drive excellence, innovation, and impact patients’ lives. Your dedication and hard work make a meaningful difference at Phathom, and we are proud to celebrate your achievements.?

This Black History Month, we recognize the groundbreaking contributions of Black scientists, healthcare professionals, and researchers whose work has shaped life sciences, advanced medicine, and improved patient care. Their legacies continue to drive innovation and progress in healthcare, and we are grateful for their integral contributions. #BlackHistoryMonth